Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Tenaya Therapeutics granted inducement stock options to newly appointed CFO Eric Hyllengren and two new non-executive employees in connection with the commencement of their employment. The grants cover an aggregate of 1,837,200 shares with an exercise price of $0.8365, equal to the closing price on July 13, 2026, and vest over four years with a one-year cliff.
Key figures
- Exercise price
- 0.8365
- Options granted cfo
- 1650000
- Options granted others
- 187200
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.